BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10099036)

  • 1. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of dopamine agonists and antagonists.
    Bianchine JR; Shaw GM; Greenwald JE; Dandalides SM
    Fed Proc; 1978 Aug; 37(10):2434-9. PubMed ID: 354976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine: receptors and clinical applications.
    Goldberg LI
    Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and dopamine receptors as target sites for cardiovascular drug action.
    Berkowitz BA
    Fed Proc; 1983 Oct; 42(13):3019-21. PubMed ID: 6137421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dopamine receptors in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S19-27. PubMed ID: 2478806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    Ziegler MG; Kennedy B; Holland OB; Murphy D; Lake CR
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):175-9. PubMed ID: 3158615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopamine receptors: fundamental and clinical aspects].
    Stoof JC
    Ned Tijdschr Geneeskd; 1986 Sep; 130(37):1638-42. PubMed ID: 2876395
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
    Goldberg LI
    Am J Med; 1984 Oct; 77(4A):37-44. PubMed ID: 6148892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and the kidney in heart failure.
    Casagrande C
    Herz; 1991 Apr; 16(2):102-15. PubMed ID: 2066052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of dopamine receptors in the cardiovascular system.
    Goldberg LI; Kohli JD
    Cardiologia; 1987 Dec; 32(12):1603-7. PubMed ID: 3447717
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma dopamine: regulation and significance.
    Van Loon GR
    Fed Proc; 1983 Oct; 42(13):3012-8. PubMed ID: 6413258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duality of dopaminergic receptors. Pharmacologic and clinical perspectives].
    Marais C
    Sem Hop; 1978 May; 54(13-16):563-7. PubMed ID: 211603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral dopamine receptors.
    Clark BJ; Menninger K
    Circ Res; 1980 Jun; 46(6 Pt 2):I59-63. PubMed ID: 6991152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine receptors and the utility of dopamine agonists in heart failure.
    Rajfer SI; Davis FR
    Circulation; 1990 Aug; 82(2 Suppl):I97-102. PubMed ID: 1973645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.